Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1

被引:26
作者
Garrido-Martin, Eva M. [1 ,2 ]
Blanco, Francisco J. [1 ,2 ]
Fernandez-L, Africa [1 ,2 ,3 ]
Langa, Carmen [1 ,2 ]
Vary, Calvin P. [4 ]
Lee, Ursula E. [5 ]
Friedman, Scott L. [5 ]
Botella, Luisa M. [1 ,2 ]
Bernabeu, Carmelo [1 ,2 ]
机构
[1] CSIC, Ctr Invest Biol, Madrid 28040, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid 28040, Spain
[3] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA
[4] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA
[5] Mt Sinai Sch Med, Div Liver Dis, New York, NY USA
基金
美国国家卫生研究院;
关键词
HEREDITARY HEMORRHAGIC TELANGIECTASIA; ETS TRANSCRIPTION FACTORS; TGF-BETA RECEPTOR; ENDOGLIN EXPRESSION; FUNCTIONAL-ANALYSIS; GENE; IDENTIFICATION; ENDOTHELIUM; ANGIOGENESIS; METHYLATION;
D O I
10.1186/1471-2199-11-51
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Activin receptor-like kinase 1 (ALK1) is a Transforming Growth Factor-beta (TGF-beta) receptor type I, mainly expressed in endothelial cells that plays a pivotal role in vascular remodelling and angiogenesis. Mutations in the ALK1 gene (ACVRL1) give rise to Hereditary Haemorrhagic Telangiectasia, a dominant autosomal vascular dysplasia caused by a haploinsufficiency mechanism. In spite of its patho-physiological relevance, little is known about the transcriptional regulation of ACVRL1. Here, we have studied the different origins of ACVRL1 transcription, we have analyzed in silico its 5'-proximal promoter sequence and we have characterized the role of Sp1 in the transcriptional regulation of ACVRL1. Results: We have performed a 5'Rapid Amplification of cDNA Ends (5'RACE) of ACVRL1 transcripts, finding two new transcriptional origins, upstream of the one previously described, that give rise to a new exon undiscovered to date. The 5'-proximal promoter region of ACVRL1 (-1,035/+210) was analyzed in silico, finding that it lacks TATA/CAAT boxes, but contains a remarkably high number of GC-rich Sp1 consensus sites. In cells lacking Sp1, ACVRL1 promoter reporters did not present any significant transcriptional activity, whereas increasing concentrations of Sp1 triggered a dose-dependent stimulation of its transcription. Moreover, silencing Sp1 in HEK293T cells resulted in a marked decrease of ACVRL1 transcriptional activity. Chromatin immunoprecipitation assays demonstrated multiple Sp1 binding sites along the proximal promoter region of ACVRL1 in endothelial cells. Furthermore, demethylation of CpG islands, led to an increase in ACVRL1 transcription, whereas in vitro hypermethylation resulted in the abolishment of Sp1-dependent transcriptional activation of ACVRL1. Conclusions: Our results describe two new transcriptional start sites in ACVRL1 gene, and indicate that Sp1 is a key regulator of ACVRL1 transcription, providing new insights into the molecular mechanisms that contribute to the expression of ACVRL1 gene. Moreover, our data show that the methylation status of CpG islands markedly modulates the Sp1 regulation of ACVRL1 gene transcriptional activity.
引用
收藏
页数:22
相关论文
共 55 条
[1]   Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2 [J].
Abdalla, SA ;
Pece-Barbara, N ;
Vera, S ;
Tapia, E ;
Paez, E ;
Bernabeu, C ;
Letarte, M .
HUMAN MOLECULAR GENETICS, 2000, 9 (08) :1227-1237
[2]  
Almendro N, 1996, J IMMUNOL, V157, P5411
[3]   Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development [J].
Arthur, HM ;
Ure, J ;
Smith, AJH ;
Renforth, G ;
Wilson, DI ;
Torsney, E ;
Charlton, R ;
Parums, DV ;
Jowett, T ;
Marchuk, DA ;
Burn, J ;
Diamond, AG .
DEVELOPMENTAL BIOLOGY, 2000, 217 (01) :42-53
[4]   IDENTIFICATION OF HUMAN ACTIVIN AND TGF-BETA TYPE-I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE-II RECEPTORS [J].
ATTISANO, L ;
CARCAMO, J ;
VENTURA, F ;
WEIS, FMB ;
MASSAGUE, J ;
WRANA, JL .
CELL, 1993, 75 (04) :671-680
[5]   Expression of endoglin and the activin receptor-like kinase 1 in skin suggests a role for these receptors in normal skin function and skin tumorigenesis [J].
Beger, B ;
Robertson, K ;
Evans, A ;
Grant, A ;
Berg, J .
BRITISH JOURNAL OF DERMATOLOGY, 2006, 154 (02) :379-382
[6]   The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2 [J].
Berg, JN ;
Gallione, CJ ;
Stenzel, TT ;
Johnson, DW ;
Allen, WP ;
Schwartz, CE ;
Jackson, CE ;
Porteous, MEM ;
Marchuk, DA .
AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :60-67
[7]   The emerging role of TGF-β superfamily coreceptors in cancer [J].
Bernabeu, Carmelo ;
Lopez-Novoa, Jose M. ;
Quintanilla, Miguel .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2009, 1792 (10) :954-973
[8]   Structure and expression of the promoter for the R4/ALK5 human type I transforming growth factor-beta receptor: Regulation by TGF-beta [J].
Bloom, BB ;
Humphries, DE ;
Kuang, PP ;
Fine, A ;
Goldstein, RH .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1996, 1312 (03) :243-248
[9]   Identification of a critical Sp1 site within the endoglin promoter and its involvement in the transforming growth factor-β stimulation [J].
Botella, LM ;
Sánchez-Elsner, T ;
Rius, C ;
Corbí, A ;
Bernabéu, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :34486-34494
[10]   Transcriptional activation of endoglin and transforming growth factor-β signaling components by cooperative interaction between Sp1 and KLF6:: their potential role in the response to vascular injury [J].
Botella, LM ;
Sánchez-Elsner, T ;
Sanz-Rodriguez, F ;
Kojima, S ;
Shimada, J ;
Guerrero-Esteo, M ;
Cooreman, MP ;
Ratziu, V ;
Langa, C ;
Vary, CPH ;
Ramírez, JR ;
Friedman, S ;
Bernabéu, C .
BLOOD, 2002, 100 (12) :4001-4010